184 results about "Lactose intolerance" patented technology

The present technology relates to an enzyme composition. The enzyme composition may be used to treat gluten intolerant subjects, including suffering from non-Celiac gluten intolerance and/or non-Celiac gluten sensitivity. The enzyme composition may also be used to reduce gluten exposure in certain individuals. For example, the enzyme composition may also be used as a prophylactic to reduce exposure to gluten oligopeptides.

Methods, compositions, and systems are provided for detecting one or more a gastrointestinal issues by characterizing the microbiome of an individual, monitoring such effects, and/or determining, displaying, or promoting a therapy for the gastrointestinal issue. Methods, compositions, and systems are also provided for generating and comparing microbiome composition and/or functional diversity datasets. Methods, compositions, and systems are also provided for generating a characterization model and/or therapy model for constipation issues, diarrhea issues, hemorrhoids issues, bloating issues, and lactose intolerance issues.

The milk powder is prepared with the materials including: fresh milk or milk powder, defatted milk powder or defatted milk, lactase, desalted whey powder, whey protein powder and/or soybean protein powder, vegetable oil, phospholipid, oligose, honey, calcium lactase, CPP, wolfberry fruit, vitamins and minerals. The product may avoid lactose intolerance, has the effects of resisting fatigue, resisting senility, raising memory and improving gastrointestinal tract function, and has the advantages of no cane sugar, high calcium content and low lactose content.

The invention discloses a smearing cheese analogue and a preparation method thereof. The smearing cheese analogue comprises the following raw materials, by weight: 15%-28% of vegetable fat, 0.2%-1.3% of a stabilizer, 0.2%-1% of an emulsifier, 5% -18% of a plant protein powder, 3%-10% of a modified starch and 45%-65% of water. The smearing cheese analogue completely uses non milk-derived ingredients as raw materials, most of which are composed of plant ingredients, does not contain cholesterol, lactose or milk fat, can satisfy consumers requiring no cholesterol or saturated fat and consumers having lactose intolerance, and is a quite healthy food. The smearing cheese analogue with light flavor is very suitable for the taste of Chinese consumers, uses the raw materials with wide sources, and has a strong price advantage. The preparation method is simple, uses easily available factory equipment, and can be applied to scale and industrial production.

The invention provides milk-like beverage compositions comprising from about 1 to about 10% of one or more caseinates, from about 1 to about 10% whey protein, from about 2 to about 10% of one or more fats, from about 0.01 to about 1% one or more hydrocolloids, and from about 0.1 to about 10% one or more emulsifiers. The compositions are formulated to have a have a realistic milk-like appearance and a nutrient profile very similar to cow milk. The compositions do not contain lactose and therefore do not cause the symptoms associated with lactose intolerance.

The invention relates to probiotic solid beverage and a preparation method thereof. The probiotic solid beverage comprises the following raw materials in parts by weight: 24 to 70 parts of maltodextrin, 20 to 60 parts of inulin and 1 to 5 parts of probiotics, wherein the probiotics comprises lactobacillus salivarius, lactobacillus acidophilus, bacillus coagulans, lactobacillus rhamnosus, bifidobacterium bifidum, lactobacillus plantarum and bifidobacterium longum. The probiotic solid beverage provided by the invention has high living bacterium quantity and can reduce loss of the probiotics whenthe probiotics pass through the gastrointestinal tract and increase the survival rate; in addition, the probiotic solid beverage can promote intestinal colonization of the probiotics; moreover, through mutual promotion of the actions of various bacteria, the probiotic solid beverage can adjust intestines and stomach well, promote intestinal tract movement, relieve constipation and diarrhea, reduce serum cholesterol, reduce lactose intolerance, accumulate proteolytic enzyme, adjust nutrient absorption and adjust the immunologic function.

The invention belongs to the processing field of milk products and particularly relates to fat-reduced, low-lactose and high-calcium milk and a preparation method of the fat-reduced, low-lactose and high-calcium milk. The milk is prepared from fat-reduced and low-lactose milk, milk mineral salts, a calcium absorption accelerant, an emulsifying agent, inulin and lactase. The preparation comprises the steps of raw material preparation, material dissolving and after-treatment. The milk has no calcium precipitate, is smooth in taste and is mellow and rich; by particularly adding a dietary fiber, namely the inulin, the intestinal tract movement of middle and aged people can be accelerated, and body burdens can be alleviated; by degrading the lactose in cow milk into micromolecular galactose and glucose which are beneficially digested and absorbed, problems caused by lactose intolerance are avoided; meanwhile, vitamins and mineral substances which are necessary nutrient elements of the middle and aged people are added into raw milk of which the lactose is degraded, so as to process and prepare a required food suitable for the middle and aged people.

The invention discloses formula milk powder for infants of 0-6 months and capable of preventing lactose intolerance and protein allergy and belongs to the technical field of formula food. Each 100g of the formula milk powder contains 12-18g of concentrated hydrolyzed whey protein powder. The concentrated hydrolyzed whey protein powder contains lactose. Each 100g of the formula milk powder contains 0-0.5g of the lactose. The formula milk powder has the advantages that the formula milk powder is suitable for the infants of 0-6 months and overcomes the symptoms of infant lactose intolerance and milk protein allergy, the concentrated hydrolyzed whey protein is used as the raw material and can well relieve the symptoms of the infant lactose intolerance, docosahexenoic acid, arachidonic acid, 1, 3-dioleoyl 2-palmitoyl triglyceride, prebiotics fructose-oligosaccharide and polydextrose components are added scientifically, lutein and nucleotide components are intensified, and the requirement of various nutritional components needed by the normal growth of the infants can be satisfied.

The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a lactose composition optionally in combination with effective amount of a probiotic, prebiotic, or both.

The invention provides methods and compostions for treating lactose intolerance. In embodiments, the invention provides methods and composition for decreasing symptoms of lactose intolerance by administering to an individual suffering from lactose intolerance increasing doses of lactose using a protocol such that at the end of treatment the individual's symptoms of lactose intolerance are decrease and such that symptoms remain decreased after a period of time.

The invention relates to the field of milk products, in particular to a formulated acidic low-lactose liquid milk product and a producing method thereof. The formulated acidic low-lactose liquid milk product contains the following raw materials by weight percent: 30 to 98.9 percent of milk, 0.31 to 1 percent of stabilizing agent, 0.3 to 0.6 percent of acidity regulator, and 0.01 to 0.1 percent oflactase of aspergillus oryzae, wherein the stabilizing agent comprises thickener and/or emulsifier, and the thickener comprises larger than or equal to 0.3 percent of low-viscosity sodium carboxymethyl cellulose by weight percent. The invention overcomes the limitation in the prior art that only neutral low-lactose milk can be produced, creatively adopts the lactase of aspergillus oryzae, provides acidic low-lactose liquid milk beverage and flavoured milk, and ensures the situation that the people suffering from lactose intolerance can drink the products becomes feasible.

The invention discloses an infant formula milk powder for preventing diarrhea and a preparation method thereof. The infant formula milk powder is prepared by blending the following raw materials in weight percent: 32-48% of maltodextrin, 12-25% of vegetable oil, 6-12% of whey protein concentrate, 6-10% of banana powder, 5-8% of apple powder, 2-8% of casein, 1-4% of mineral premix, 1.0-2.5% of fructo-oligosaccharide, 0.3-1.0% of galactooligosaccharide, 0.5-1.5% of immune globulin G, 0.1-0.6% of ARA (arachidonic acid), 0.1-0.45% of DHA (docosahexaenoic acid), 0.05-0.8% of vitamin premix, 0.06-0.1% of lactoferrin, 0.05-0.1% of taurine and 0.02-0.08% of nucleotide. The invention further discloses the preparation method for the infant formula milk powder for preventing diarrhea. The infant formula milk powder is especially suitable for infants with lactose intolerance or infants who easily suffer from lactose intolerance in the diarrheic period to eat.

The invention relates to a low-lactose milk preparation method which comprises the following steps: (1) mechanical impurities of raw milk are removed by milk purification technique; (2) raw milk after purification is sterilized at ultra-temperature or pasteurized and then cooled to temperature below 8 DEG C; (3) milk compound is prepared; (4) the prepared milk compound is sterilized at ultra-temperature or pasteurized and cooled; (5) lactase preparation is added under aseptic condition; (6) the milk is bottled sterilely. The milk compound in step (3) also comprises: 0.1-10 wt parts of dietary fiber for increasing the health care function of the milk and further comprises essence less than 2 parts by wt. The method of the invention overcomes the shortcoming of low lactose hydrolysis rate of the prior technique. The product prepared by the method of the invention has good stability, and is particularly suitable for people with severe lactose intolerance symptom. The invention is also added with dietary fiber in the formula.

Methods of determining gastro-intestinal conditions by performing a succession of breath tests or others tests, particularly for determining the gastric emptying or gastric accomodation condition of a subject. Methods of performing successive gastric emptying tests with different test meals are also presented, enabling the gastric accommodation to be determined. The effects of different test means on the results is presented. Novel substrates for use in such tests are suggested, including the use of micro-encapsulation. Breath tests for the detection of bacterial overgrowth, lactose intolerance and combinations thereof are presented.

The invention relates to soybean-based infant formula powder and a preparation method thereof. The infant formula powder is mainly refined by using isolated soybean protein, soybean powder, whey powder, whole milk powder, corn starch, white granulated sugar, mineral substance and composite vitamin. In the preparation method, the isolated soybean protein is hydrolyzed by using phytase, so that thehydrolysis rate, the hydrolysis foaming force and the soaking duration of the isolated soybean protein are greatly improved; and after enzymolysis, the nutrition titer of soybean can be remarkably improved. The soybean-based infant formula powder is suitable for infants suffering from milk protein allergy and lactose intolerance, and is also suitable for normal infants.

The invention provides a food for treating lactose intolerance and diarrhea of infants. The food is mainly formed by mixing 5-25 parts of maltodextrin, 5-25 parts of anhydrous dextrose, 3-15 parts of fructo-oligosaccharide, 0.5-2.5 parts of dried skim milk, 0.1-0.5 part of bifidobacterium lactis, 0.1-0.5 part of lactobacillus rhamnosus and 0.1-0.5 part of lactase. The invention further discloses a preparation method of the food. The lactase, probiotics and prebiotics are organically combined to establish a novel method for treating the lactose intolerance and the diarrhea. The fructo-oligosaccharide can be used for promoting the probiotics in a human body to be greatly multiplied; the activity of the lactose can be improved by the probiotics, and the lactase can promote the multiplication of the probiotics, the lactase and the probiotics are mutually promoted to bring out the best in each other, the effect of treating the lactose intolerance and the diarrhea is greatly improved, the lactose intolerance and the diarrhea are basically treated, and the intestinal health is protected. Through clinical verification, the effective rate of treating the lactose intolerance and the diarrhea of infants is up to more than 93% and the food has the active effects of convenience for drinking and obvious health-care effect.

The invention relates to a preparation method of milk peptides and a technique process thereof is that butter in raw milk is first separated from skimmed milk which is then treated with hydrolysis, enzymolysis, bleaching, filtering and concentration; hydrolysate and butter are next treated with complex formulation or not according to customer needs of customer to produce the milk peptide I and the milk peptide II. Raw materials of the invention are easy to be obtained and made full use of; the technology and special composite protease are advanced; in addition, the invention has the advantages of high-yield of milk peptides, low cost and good quality of products and is easy to be popularized by manufacturers. The milk peptides prepared by the method of the invention can be widely used for infant milk powder, dairy products for groups of people who have lactose intolerance, dairy products for special groups, food enhancers, etc.

The invention discloses an L-amlodipine benzene sulfonate tablet which contains fewer auxiliary materials, but can keep higher dissolution performance and higher stability, and a preparation process of the L-amlodipine benzene sulfonate tablet. Per 10000 L-amlodipine benzene sulfonate tablets contain 34.66g of L-amlodipine benzene sulfonte, 280-420g of microcrystalline cellulose, 280-420g of calcium sulfate, 72-108g of hydropropylcellulose and 6.4-9.6g of magnesium stearate. The L-amlodipine benzene sulfonate tablet contains fewer auxiliary materials and is particularly free of lactose in the formula, is simple in preparation process, contains fewer related substances, but can keep higher dissolution performance and higher stability; and microcrystalline cellulose and calcium sulfate are used as filling agents, hydropropylcellulose is used as the adhesive and disintegrant, and magnesium stearate is used as the lubricant, and the formula is free of lactose, so that the tablet is also suitable for the patients suffering from lactose intolerance disease.

The invention relates to a soy-based milk powder and a preparation method thereof. At present, some babies having special constitution have lactose intolerance when eating formula milk powder and are allergic to milk protein. Aiming at the phenomenon, the invention provides a baby formula milk powder which does not contain lactose or milk protein. The baby formula milk powder comprises the following materials in weight parts: 160-190 parts of isolated soy protein, 100-110 parts of sucrose, 290-315 parts of vegetable oil, 460-480 parts of malt syrup, 7.5 parts of honey, 40 parts of fructooligosaccharide, 20.8 parts of isomaltooligosacharide, 2 parts of compound vitamin and 4.75 parts of mineral substances. The soy-based milk powder is a formula milk powder.

A composition and method for treating and/or preventing acute and chronic gastrointestinal distress including nausea, vomiting, lactose intolerance, obstructive symptoms, diarrhea, mucositis, bleeding, weight loss, and malnutrition in a subject who is immunocompromised or receives a planned course of chemotherapy and/or radiotherapy. The method comprises administering a histone deacetylase inhibitor or in conjunction with a second agent to the subject. A composition and method using a histone deacetylase inhibitor for protecting normal tissues from chemotherapy and/or radiotherapy-induced injuries without the risk of tumor protection in cancer therapy is also provided. It is further provided a composition and method for treating and/or preventing cachexia, cancer-related fatigue, or chronic fatigue syndrome.